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The ability to accurately predict the DNA targets and interacting cofactors of
transcriptional regulators from genome-wide data can significantly advance
our understanding of gene regulatory networks. NKX2-5 is a homeodomain
transcription factor that sits high in the cardiac gene regulatory network
and is essential for normal heart development. We previously identified
genomic targets for NKX2-5 in mouse HL-1 atrial cardiomyocytes using
DNA-adenine methyltransferase identification (DamID). Here, we apply
machine learning algorithms and propose a knowledge-based feature selection
method for predicting NKX2-5 protein : protein interactions based on motif
grammar in genome-wide DNA-binding data. We assessed model perform-
ance using leave-one-out cross-validation and a completely independent
DamID experiment performed with replicates. In addition to identifying
previously described NKX2-5-interacting proteins, including GATA, HAND
and TBX family members, a number of novel interactors were identified,
with direct protein : protein interactions betweenNKX2-5 and retinoid X recep-
tor (RXR), paired-related homeobox (PRRX) and Ikaros zinc fingers (IKZF)
validated using the yeast two-hybrid assay. We also found that the interaction
of RXRa with NKX2-5 mutations found in congenital heart disease (Q187H,
R189G and R190H) was altered. These findings highlight an intuitive approach
to accessing protein–protein interaction information of transcription factors in
DNA-binding experiments.1. Introduction
Complex gene regulatory networks (GRNs) guide development and tissue
homeostasis in all organisms. While gene regulation is complex, transcription
factors (TFs) provide a key focus for effector function in GRNs as their specific
DNA recognition sequence motifs (transcription factor binding sites, TFBSs) are
hard-wired into the genome sequence [1,2]. TFs do not act in isolation, and the
progression of diverse cellular programmes in development depends upon
binding site specificity, cooperativity of multiple TFs and the recruitment of a
diversity of cofactors [3–7].
Recently, machine-learning algorithms have been applied to genome-wide
datasets tomake novel predictions related to cardiac GRN function. These studies
have focused on predictingmuscle-specific enhancers fromvalidated training sets
[8,9] or identifying known and novel TFs governing heart precursor and organ
development based on sequence-level discriminators (motif grammar) [10,11].
While such studies have demonstrated the powerofmachine-learning approaches
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cers based on motif grammar, these methods have not yet
been systematically focused on the discovery and validation
of novel TF protein interactors—therefore relatively few such
transcriptional cofactors have come to light. Furthermore,
while large numbers of TFs have been proposed to act through
indirect DNA binding [12,13], the nature and role of cofactors
that indirectly guide TFs to regulatory elements has not been
clarified or systematically validated.
NKX2-5 is an NK2-class homeodomain TF related to
Drosophila tinman, and its expression duringmammalian devel-
opment is regionally restricted to the cardiac fields and forming
heart tube, aswell as other organ-specific domains [14]. Consist-
ent with a combinatorial model for TF specification of heart
development, NKX2-5 acts cooperatively with other cardiac
TFs whose expression is similarly regionally restricted, includ-
ing GATA4, ISL1, TBX2/3/5/20, MEF2C and SRF. These
factors are thought to form a cardiac collective or ‘kernel’ of
TFs that show recursive wiring (many cross-regulatory inter-
actions) [1] and which perform the executive functions of the
cardiac GRN. NKX2-5 is essential for normal heart develop-
ment and mouse embryos carrying homozygous NKX2-5
loss-of-function or severe point mutations show a rudimentary
beating myogenic heart tube lacking specialized chambers,
valves, septa and conduction tissues, with subsequent growth
arrest and death at mid-gestation [15]. In humans, NKX2-5 is
also one of themost commonlymutated single genes in congen-
ital heart disease (CHD), with heterozygous mutations
causative for a spectrumofCHDphenotypes,most prominently
atrial septal defects and progressive conduction block [15].
To expand our knowledge of the cardiac GRN, we recently
identified NKX2-5 targets in cultured HL-1 atrial cardiomyo-
cytes using DNA-adenine methlyltransferase identification
(DamID), a sensitive enzymatic method for detecting genome-
wide protein–DNA interactions [16]. DamID complements
the chromatin immunoprecipitation (ChIP) method for detec-
tion of TF-DNA interactions while avoiding some of the
artefacts associated with chromatin cross-linking and use of
poor quality antibodies [16,17]. Approximately 1500 target
peaks were detected and, consistent with a role for NKX2-5
in normal heart development, proximal target genes were
enriched for those involved in cardiac development and
sarcomere organization.
Further analysis of our DamID data [16] and ChIP data [11]
identifying genome-wide cardiac TF target sets suggests that
cardiac kernel TFs collaborate and interact widely with each
other and with many broadly expressed signal-gated DNA-
binding TFs. This includes factors embedded within canonical
signalling pathways such as SMAD and TCF proteins (down-
stream of BMP and WNT signalling, respectively), known to
regulate cardiogenesis, as well as other extracellular signal-
gated TFs of the ETS, TEAD, NFAT, STAT, YY, SP, LMO
and MEIS families [8,18–21]. A model in which regionally
restricted kernel TFs cooperate with broadly expressed but
signal-gated TFs to define an organ-specific context for devel-
opmental programmes is compelling because it allows for
great regulatory flexibility, consistent with the GRNmodel [1].
In this study, we applied machine-learning algorithms to
generate models for wild type (WT) NKX2-5 targets based on
motif grammar, exploiting replicate NKX2-5 DamID exper-
iments performed 2 years apart [16]. We developed a
knowledge-based lasso method to generate sparse models
with very high concordance between experiments. Using thisapproach, we defined 27 TFs as discriminators of NKX2-5
DamID targets that included NKX2-5 and related proteins, as
well as known direct NKX2-5 protein interactors such as
TBX5, GATA1 and HAND1. We also identified novel NKX2-
5 target discriminators and validated retinoid X receptor
(RXRa), paired-related homeobox (PRRX2), Ikaros zinc fingers
(IKZF1) and a number of their paralogues (PRRX1a, PRRX1b,
IKZF3 and IKZF5) as direct NKX2-5 interactors using the
yeast two-hybrid assay. Furthermore, we found that inter-
actions between RXRa and a subset of NKX2-5 mutations
causative for congenital heart disease (Q187H, R189G and
R190H) were altered, linking TF–TF interaction networks to
heart disease. To our knowledge, these are the first experiments
to mine genome-wide TF–DNA interaction data for systematic
discovery and validation of TF protein–protein interactions
(PPIs) for expanding TF interactomes.2. Results
2.1. Classification of bound regions by motif
composition
We previously identified 1536 and 1571 NKX2-5 target peaks,
respectively, in two DamID experiments performed 2 years
apart [16]. Three and four replicates, respectively, contributed
to peak selection in these experiments, which we refer to as
NKX2-51 and NKX2-52 [22]. The peak overlaps between
NKX2-51 and NKX2-52 were highly significant (p, 0.001)
and comparison of gene ontology (GO) terms using a log
odds ratio statistic implemented in the CompGO R package
demonstrated these experimentswere identical at aGOlevel [22].
We sought to determine if NKX2-5 targets could be
classified based on the motif grammar embedded within
their peaks, relative to a random peak set generated from
sequences represented on the Affymetrix promoter micro-
array chip used for DamID experiments [16]. For testing
models, we used a leave-one-out cross-validation (LOOCV)
approach to train models for NKX2-51 (compared with the
randomly generated peak set) on 75% of the data, withhold-
ing 25% for testing performance (figure 1a). We used DREME
[23] to generate position weight matrices (PWMs) de novo
from the training sets only, which identified 70 de novo
PWMs in total (figure 1b; electronic supplementary material,
file S1). We next combined these de novo PWMs with PWMs
from Transfac [24] and Jaspar [25], adding the PWM for
TBX5, a known NKX2-5 cofactor [26] (figure 1b; electronic
supplementary material, file S2), bringing the total number
of PWMs to 1202. CLOVER [27] was next used to count
motif instances in NKX2-5 target peaks, followed by normal-
ization to peak length. From de novo motifs discovered, the
NKX2-5 motif (NKE) was highly enriched (ranked first for
NKX2-51 and shown in figure 1b, and third for NKX2-52),
consistent with previous findings [16].
We then generated classification models using three
algorithms—least absolute shrinkage and selection operator
(lasso) [28], support vector machine (SVM) [29] and random
forest [30] (figure 1c)—and compared predictive performance
using the area under curve (AUC) of receiver operating charac-
teristic (ROC) graphs from the withheld test set (figure 1d ).
Performance of the lasso model on the test set resulted in an
AUC of 0.789 (where 0.5 is random) (figure 1d). Removing
de novo motifs from the feature matrix and refitting the
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Figure 1. Predictive workflow for identification of novel PPIs. The process of building and testing models is illustrated as four steps from (a) to (d). (a) Partition data:
NKX2-5 and random peaks were randomly partitioned into training (75%) and test (25%) sets. (b) Generate feature set and count occurrences: PWMs were determined de
novo from training sets only and appended to an existing set of known PWMs. Motif occurrence was determined using CLOVER and normalized to peak length. (c) Train
models: lasso, random forest and SVM models were trained and therefore generated from feature set data. (d ) Evaluate models: receiver operator characteristic (ROC) curves
for the lasso, random forest and SVM algorithms evaluated against the withheld test set. Blue lines, SVM; red lines, lasso; black lines, random forest; dashed lines cor-
respond to removal of de novo motifs. (e) Overlap of test peaks correctly predicted as NKX2-5 positive or random using the lasso, SVM and random forest methods.
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1% classification performance. AUCs of the SVM and
random forest models using all motifs were 0.801 and 0.788,
respectively, a marginal AUC improvement (0.012) or loss
(20.001) comparedwith the lassomodel (figure 1d ). Removing
de novo motifs again did not affect performance (figure 1d ).
This indicated that known TFBSs were sufficient to predict
NKX2-5 peaks. NKX2-5 test peaks predicted correctly by the
SVM and random forest models overlapped highly with the
lasso predicted peaks, identifying a common set of 280 positive
peaks (approx. 78%) (figure 1e). Specificity and sensitivity
analysis (equations (5.1) and (5.2); see Material and methods)
revealed that the random forest was the most sensitive, pre-
dicting 88.7% as true positive peaks compared with the SVM
(83.1%) and lasso (72.5%) (equation (5.1)). However, this was
at the cost of specificity. The random forest model predicted
the smallest proportion of true negative peaks (53.6%), fol-
lowed by the SVM (63.2%) and lasso (70.6%) (equation (5.2)),
suggesting a larger proportion of false positive predictions by
the random forest and SVM models, and possibly overfitting
by these models. Although these trade-offs were reflected bythe overall similarity of their AUC values in the ROC curves
(figure 1d), the lasso had the greatest positive predictive
value (PPV, equation (5.3)), correctly predicting the largest
proportion (73.5%) of true positive peaks among all positive
predictions, followed by the SVM (71.7%) and random
forest models (68.2%). Consistent with these results, the lasso
model had the lowest false discovery rate (FDR) (equation
(5.4); see Material and methods) at 0.265, followed by the
SVM (0.283) and random forest (0.318). As our aim was to
identify new PPIs with greatest confidence for further vali-
dation, we proceeded with the lasso algorithm, having the
greatest PPV and the lowest FDR.2.2. Assessing repeated NKX2-5 DamID binding
experiments
We then examined the similarity between distinct NKX2-5
experiments by applying lasso models generated from NKX2-
51 to test peaks obtained from NKX2-52 and vice versa,
and assessed sensitivity of predictions (equation (5.1)). The
NKX2-52
NKX2-52
NKX2-51
NKX2-51 versus NKX2-52
A versus B1
B2 versus C
A versus C
NKX2-51
666 870 701
A B1
B2 C
1.0
0.8
0.6
0.4
tr
ue
 p
os
iti
v
es
0.2
0
1.00.80.6
false positives
0.40.20
(a) (b)
Figure 2. Classification accuracy of unique and common genomic regions from repeated experiments. (a) Peak overlaps of NKX2-51 and NKX2-52. Coloured boxes
beneath match the venn diagram colours and represent the A, B1, B2 and C defined peaks, where A are unique peaks to NKX2-51, B1 are the NKX2-51 peaks that
overlapped with NKX2-52 peaks (vice versa for B2) and C are unique peaks to NKX2-52. (b) ROC curves illustrating test set performance of models generated from
direct comparison of NKX2-5 experiments as well as overlapping and non-overlapping genomic coordinates.
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NKX2-52 peaks was 0.741 if de novo motifs were included
and 0.731 without de novo motifs. It is noteworthy here that
the sensitivity of predictionwasmuch greater than the approxi-
mately 55% of peak coordinates identified as overlapping
between NKX2-51 and NKX2-52 (figure 2a) (see below).
To determine the importance of unique as well as common
genomic targets in the overlap depicted in figure 2a for gener-
ating our models, data were split into A, B1, B2 and C sets,
where A represented the peaks unique to NKX2-51, B1 rep-
resents the specific peaks originating from NKX2-51 which
overlap with NKX2-52 peaks, B2 the peaks originating from
NKX2-52 which overlap with NKX2-51 peaks, and C the
peaks unique to NKX2-52. Positive predicted peaks (including
de novo motifs) for each set of peaks followed: A (75.1%), B1
(80.2%), B2 (79.2%) and C (69.5%). An important insight here
is that the non-overlapping A and C sets do not represent a
random signature, consistent with our previously described
GO term analysis of repeated NKX2-5 experiments, which
showed that peaks unique to each experiment were enriched
in similar GO categories [22]. Overlapping peaks (B sets) did,
however, demonstrate improved sensitivity by 5–10%, and
there was a small bias towards unique peaks (A versus C
sets) from the experiment that the model was generated
from. Results were consistent when excluding de novo motifs
and when models were generated from NKX2-52 versus
random peaks and applied to A, B and C sets. However, the
model for NKX2-52 was much larger, with 142 features com-
pared with 71 features for the NKX2-51 model, and the
number of positive peaks was slightly higher: A (71.2%), B1
(84.5%), B2 (83.6%) and C (77.6%).
It seemed unlikely that the increased number of features in
NKX2-52 could be explained by unique binding qualities of
NKX2-5 between the two experiments or fundamental differ-
ences in the target cell states, given the similar number of
peaks detected in NKX2-51 and NKX2-52, as well as the com-
plete overlap in GO terms. The differences may rather relate
to the inclusion or exclusion of borderline motifs in the
models. To explore this further, we built models to compare
each experiment directly (in contrast to comparing each to a
random set) and all combinations of A, B and C (figure 2a)seeking features that might be unique to each experiment.
Using the NKX2-51 training set versus the NKX2-52 training
set, a classification model generated only four motifs (of
which three were de novo) and the model performed poorly
when applied to the withheld test data (AUC of 0.534)
(figure 2b). Similarly, for A versus B, B versus C and A versus
C, smallmodelswere generated (1, 1 and 6motifs, respectively)
with poor AUC performance (0.516, 0.569 and 0.508, respect-
ively). The motifs present in the A versus C model were also
present in the NKX2-51 versus NKX2-52 model (electronic
supplementary material, figure S1). These results demonstrate
that both NKX2-5 experiments, including their unique peaks,
consistently captured peaks with similar TF binding site
composition. Notably, the A and C peak sets showed similar
features and are not artefacts (see Discussion).2.3. Prediction of NKX2-5 protein : protein interactions
Our aim to experimentally detect and validate novel PPIs
requires that we predict the smallest number of high-
confidence targets for experimental follow-up. Because the
lasso algorithm selects features by shrinking less relevant
coefficients to zero through application of a l penalty (via
L-1 regularization; the shrinkage parameter), we investigated
the model characteristics further. Removing de novo motifs
(i.e. using only previously described motifs) and refitting a
model for NKX2-51 reduced the model size from 71 to 51 fea-
tures (reduction of model size to approx. 72%) while only
reducing classification performance by approximately 1%
(AUC of 0.779). Considering this marginal loss of perform-
ance and the potential difficulty in associating de novo
sequences to their cognate TFs, we continued to investigate
the model based on previously described motifs. In addition,
noting that the number of motifs included in the NKX2-52
model was much larger than that for NKX2-51 (112 versus
51), investigation of the l curves revealed two differently
shaped curves that resulted in a sparser model for NKX2-51
(smaller number of features before reaching the 1 s.e. point
of model selection) compared with NKX2-52 (electronic
supplementary material, figure S2).
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Figure 3. Knowledge-based model features. (a) Motifs remaining in NKX2-51 and NKX2-52 models after knowledge-based lasso modelling; green indicates present
as a feature, black not present. Hierarchical clustering was performed in STAMP [32] using default parameters, except trimming was disabled. (b) Motifs of the
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Red boxes are to highlight the high-affinity NKX2-5 motif.
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to reduce model size further, assessing the concordance of the
models derived from replicate experiments. We hypothesized
that the smallest predictive model for NKX2-5 would include
NKX2-5 itself—the knowledge. We therefore continued to
compress the lasso model until the point just before the
known high-affinity NKX2-5 motif (‘NKX2-5 (M00240, Trans-
fac)’; NKE) [31] was lost from our model (l of approx. 0.071;
electronic supplementary material, figure S2a). This resulted
in a model with 25 features for NKX2-51 (including a cluster
of four motifs for other NK2-class homeodomain family mem-
bers NKX2.2, 2.4 and 3.2, possibly representing alternative
forms of the NKX2-5 TFBS), halving the model size and
decreasing test AUC performance by only 0.020 (AUC 0.759).
Similar results were achieved for the NKX2-52 experiment
versus random (l of approx. 0.078; electronic supplementary
material, figure S2b), where 18 of 20 features overlapped withthe 25 features from the NKX2-51 knowledge-based model
(figure 3a,b). Notably, our knowledge-based model was no
longer biased towards experimental origin, although overlap
bias remained—that is, peaks common to NKX2-51 and
NKX2-52 (represented as B1/B2 set; figure 2a) were predicted
correctly more often: A (67.3%), B1 (75.1%), B2 (75.2%) and C
(67.7%). This suggests that the knowledge-based approach
was superior in eliminating model origin bias, consistent
with results from fitting models directly against each other.
Many of the motifs included in this knowledge-based
model were known NKX2-5 protein–protein interactors
[16,33], speaking to the validity of the proposed approach.
Motifs for known NKX2-5 PPIs common to both models
included T-Box 5 (TBX5) [26], heart and neural crest derivatives
expressed (HAND; MA0092.1), SP-1/ETS TFs (MA0081.1),
and nuclear factor I (NF-I; MA0161.1 and M00193) [16].
NKX2-51 but not NKX2-52 features included known NKX2-5
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and tumour suppressor protein p53 (p53; M00272) [34,35].
Potentially novel NKX2-5 PPIs included myeloid zinc finger
1 (MZF1;MA0056.1), MYOD myogenic differentiation factor
(MyoD;M00184), jun proto-oncogene (JUN/AP-1; M00199),
TF AP-2/AP-4 (AP2/4; M00469, M00175), retinoid X receptor
a (RXRa; MA0512.1), IKAROS family zinc finger 1 (IKZF1/
LYF-1; M00141), zinc finger E-box binding homeobox 1
(ZEB1, also called AREB6; M00415) and paired-related
homeobox 2 (PRRX2; MA0075.1).
Our knowledge-based models allow the possibility that
WT NKX2-5 binding to DNA can be mediated by indirect
as well as direct tethering to chromatin, as demonstrated
for NKX2-5 mutant proteins [16], and thereby are potentially
predictive of novel NKX2-5 PPIs that mediate indirect bind-
ing. We would expect, therefore, that a proportion of
detected motifs would not co-occur with the NKX2-5 motif
(NKE) in peaks. We assessed motifs common to both exper-
iments and their frequency in NKX2-51 peaks (figure 3c).
Note that in figure 3c the proportions along the diagonal
can be less than one, as this indicates prevalence of the
TFBS among all peaks detected. With the exception of
TBX5, which was present in a high proportion of NKX2-5
peaks, this analysis did not reveal a strong co-occurrence of
NKX2-5 with the other TF binding sites detected. Subtracting
NKX2-5 motif frequency from the frequency of other motifs
detected revealed that, for each predicted motif, approxi-
mately 8–29% of peaks containing these motifs did not
co-occur with the high-affinity NKX2-5 motif (figure 3d ).
These results support the hypothesis that NKX2-5 can bind
to a subset of targets indirectly via PPIs.
The high co-occurrence of TBX5 motifs and the majority
of other discriminators may have biological relevance [36],
although may also reflect a relatively low information content
of the TBX5 PWM.
2.4. Testing novel NKX2-5 protein–protein interactions
Identification of motifs in our lasso models that occur fre-
quently in the absence of the high-affinity NKX2-5 TFBS
suggests that TFs binding to these motifs might associate
with NKX2-5 via PPIs to either recruit NKX2-5 specifically
to these sites or interact on enhancers as part of higher
order protein complexes. Searching PPI databases IntAct
[37], HPRD [38], STRING [39] and BioGRID [40] for the
term ‘NKX2-5’ revealed a small network of 31 known inter-
actions (electronic supplementary material, figure S3 and
table S1), from which we identified GATA4, SRF, TBX5 and
HAND1 in our lasso models. Our model outputs suggest
that there are many other possible NKX2-5 PPIs relevant to
the cardiac GRN. Previous work focusing on the broadly
expressed signal-gated ETS family TFs, ELK1 and ELK4,
which are directly interacting cofactors of NKX2-5, showed
that these were highly integrated in the cardiac GRN with
many cross-regulatory interactions [16].
2.5. Testing novel PPIs
To test whether unexpectedmotifs predicted inNKX2-5 targets
correlate with novel NKX2-5 protein–protein interactors, we
used the Y2H assay [16]. We fused NKX2-5 to the GAL4-
activation domain (GAL4-AD) and its potential protein
interactors to the GAL4 DNA-binding domain (GAL4-DBD).We initially tested six predicted and potentially novel PPIs
from the knowledge-based model (RXRa, PRRX2, IKZF1,
TFAP4, MyoD and ZEB1) and compared results to a set of
TFs derived from randomly selected PWMs from the 1132
motifs used in this study (msh homeobox MSX1; glucocorti-
coid modulatory element binding protein 1 GMEB1; zinc
finger and BTB domain containing 11 and 12 ZBTB11/12;
Kruppel-like factor 10 KLF10; and nuclear TF Y-g NFYC). We
also included control vectors for expression of the GAL4-
DBD and -AD alone. Using the Y2H assay under selective
conditions, we confirmed that NKX2-5 fused to GAL4-AD
bound specifically to GAL4-DBD fusions containing NKX2-5
itself, RXRa, PRRX2 or IKZF1/LYF, but not TFAP4/AP-4,
ZEB1,MyoDor to anyof the negative controls (figure 4a,b; elec-
tronic supplementary material, figure S4a). GAL4-DBD fusion
expression was assessed by western blot using an antibody
specific to the c-MYC tagpresent in theDBDfusions,which con-
firmed that RXRa, PRRX2, IKZF1 and TFAP4, as well as all
negative controls tested,were expressed at the expectedmolecu-
lar weight (MW) in yeast (figure 4c; electronic supplementary
material, figure S4b). ZEB1, however, showed little if any full-
length protein and several degradation products, possibly due
to its larger size (approx. 144 kDa). We therefore sub-cloned
five overlapping sub-fragments of ZEB1/AREB6 spanning the
whole protein (electronic supplementary material, figure S4c).
Although expressed at the expected MWs, the N- and
C-terminal ZEB1/AREB6 fragments, which contain the Zinc-
finger clusters, failed to interact with NKX2-5 (electronic
supplementary material, figure S4c,d). When fused to the
GAL4-DBD, all the fragments encompassing the ZEB1 homeo-
domain resulted in background yeast growth, even when
expressed with GAL4-AD alone. Therefore, PPIs between
NKX2-5 and fragments containing the ZEB1 homeodomain
could not be assessed properly in this system. Our results
validated direct PPIs for three of the six TFs newly predicted
from the knowledge-based model to bind to NKX2-5 targets,
expanding the known NKX2-5 PPI network by 10% in this
small validation screen. When considering previously known
NKX2-5 PPIs also present in the model, we estimate that our
predictive performance is in the range of approximately 60%
(when including those untested as negative) to 80% (when not
considering those untested).
2.6. Testing paralogues of novel NKX2-5 PPIs
Paralogous TFs are often reported to bind the same TFBS [41].
We therefore hypothesized that the motifs predicted by our
model could represent binding of paralogous TFs for which
no PWM was currently available, and so we extended our
NKX2-5 PPI screen to paralogues of RXRa, PRRX2 and
IKZF1. We found that NKX2-5 fused to GAL4-AD interacted
with GAL4-DBD fusions containing transcript variants
PRRX1a and PRRX1b, which are overall approximately 60%
identical and paralogous to PRRX2 (figure 4d,e). Further-
more, IKZF3 (also known as Aiolos; figure 4d,e) and IKZF5
(also known as Pegasus; electronic supplementary material,
figure S4e), which are overall 55% and 22% identical, respect-
ively, to IKZF1, could also bind NKX2-5. These interactions
are likely to occur through the first zinc-finger of the C-term-
inal dimerization domain (electronic supplementary material,
figure S4e). However, while NKX2-5 interacted with RXRa, it
did not interact with its paralogue RXRg, which is overall
60% identical to RXRa.
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Figure 4. Validation of predicted PPIs by yeast-2-hybrid assay (Y2H). (a) Yeast transformed with the GAL4-activation domain (AD) alone, control, or fused to NKX2-5
and the GAL4-DNA-binding domain (DBD) alone (control) or fused to potential NKX2-5 protein interactors. Positive signs (þ) show interaction as growth on selective
medium (high stringency, -Leu/-Trp/-Ade/-His). (b) Representative picture of PPIs tested. Transformants were grown on non-selective (low stringency, -Leu/-Trp)
before two clones were picked onto plates containing low or high stringency medium. (c) Detection of GAL4-DBD-Myc fusions by western blotting with anti-Myc
antibodies. (d ) Representative picture of PPIs tested with paralogues of novel NKX2-5 PPIs fused to the GAL4-DBD and grown on plates containing selective medium
at four dilutions. (e) Detection of GAL4-DBD-Myc fusions by western blotting with anti-Myc antibodies. Coloured arrowheads indicate the expected molecular weight
of control (red) or potential interactors (yellow).
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Having identified novel PPIs, we next determined whether
known CHD-causing mutations in NKX2-5 demonstrated
impaired or altered binding to these PPIs. Mice lacking RXRa
display a large spectrum of severe cardiac defects, including
abnormal septation, ventricular phenotypes resulting from
lack of expansion of the compact zone ofmyocardium and dys-
regulated trabecular morphogenesis [42], and these overlap
with defects seen in NKX2-5 heterozygous and hypomorphic
models [43–45]. We therefore tested a panel of five NKX2-5
point mutations in the homeodomain associated with heart
disease: Q187H, N188 K, R189G, R190H and Y191C [46–48].
Three of the five mutants (Q187H, R189G and R190H) demon-
strated a decreased interaction with RXRa when compared
with NKX2-5 WT (figure 5a,b). For Q187H, this could beattributed to the lower expression observed in yeast as
determined by western blotting (figure 5a,c). However, for
R189G and R190H, expression in yeast was higher compared
with that ofWT, indicative of a true impairment of the PPI. Sur-
prisingly, N188K interacted more strongly with RXRa than
NKX2-5 WT, possibly because it showed increased expression
or stability (figure 5a,c). These results suggest that the novel
NKX2-5 PPI with RXRa identified here is critical for normal
heart development and is disrupted in CHD caused by
NKX2-5 homeodomain mutations.3. Discussion
The ability to accurately predict DNA targets and interacting
cofactors of transcriptional regulators from genome-wide
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Figure 5. Testing PPIs between RXRa and NKX2-5 wild type (WT) or mutant yeast two-hybrid assay (Y2H). (a) Yeast transformed with the GAL4-activation domain
(AD) alone (control) or fused to NKX2-5 proteins and the GAL4-DNA-binding domain (DBD) alone (control) or fused to RXRa. Positive signs (þ) show interaction as
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GRNs and processes underlying disease. Here, we sought
to determine if DNA regions detected as bound by NKX2-
5, a TF essential for heart development, could be used to
predict novel NKX2-5 protein interactors. We then syste-
matically tested novel candidate PPIs and their paralogues
for binding to NKX2-5, and, in the case of RXRa, for binding
to NKX2-5 mutants using the yeast two-hybrid assay.Exploiting NKX2-5 DNA-binding experiments that were
repeated 2 years apart [16], we first investigated reproducibi-
lity by applying machine-learning algorithms to explore
TFBS patterns in each experiment. This led to the develop-
ment of a knowledge-based method for variable selection
(i.e. model shrinkage), based on our assumption that aminimal
model should contain NKX2-5 itself. Our knowledge-based
method significantly improved model concordance between
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correctly predicted bound regions of the other experiment with
up to 80% accuracy compared with randomly selected peaks,
far greater than the approximately 55% overlap of genomic
coordinates (figure 2a). Concordance of our knowledge-
based models from each experiment (figure 3a) reflected an
underlying consistency of motif grammar, consistent with
our previous finding of identical enriched GO terms between
NKX2-51 and NKX2-52 target gene sets [22]. This suggests
that each repeated experiment captures a unique subset of
NKX2-5 binding sites that nonetheless have similar underly-
ing motif composition. It is plausible that cells could have
been exposed to slightly different environments (e.g. culture
serum batch), representing a cell non-autonomous influence,
albeit one that does not alter the binding logic of NKX2-5 or
instigate global changes in GO terms of targeted genes. It has
been proposed that alternative states exist within GRNs that
contribute to robustness [49]. Typically, this concept has been
used to explain variability inherent in signal transduction cir-
cuits [50], gene or protein expression variability [51] and,
conversely, constraints or non-robustness that lead to disease
[52]. Lack of complete overlap from our repeated DNA-
binding experiments, but with an underlying concordance of
GO and motif grammar, indicates that we need to consider
whether variation between different DNA-binding experi-
ments or platforms indeed reflects noise or alternatively
different biologically relevant GRN ‘states’. These findings
shed light on the topical issue of the poor reproducibility of
DNA-binding experiments, typically assessed through simple
overlap metrics [53,54].
Our knowledge-based models identified a number of pre-
viously described NKX2-5 PPIs (GATA, HAND and TBX
factor families) as being important features, supporting our
hypothesis that these data could be used to predict novel
NKX2-5 protein interactors. However, the majority of our pre-
dictions had not been previously described to interact with
NKX2-5. We went on to test these predictions using the Y2H
assay and validated 50% of the tested TFs as true NKX2-5
protein interactors: RXRa, PRRX2 and IKZF1/LYF-1. Of the
PPIs that did not validate (TFAP4/AP-4, ZEB1 and MyoD),
we found that this could be explained by motif redundancy.
For example, the ZEB1/AREB6 motif is the reverse comp-
lement of that for FOXO4 (M00472) (figure 3a,b). FOXH1, a
FOXO4 paralogue, has been previously described to interact
with NKX2-5 [55]. MyoD could not be tested using the Y2H
system, having a large amount of non-specific activity in the
controls (data not shown). However, the MyoD and TFAP4
motifs clustered together and represent the canonical E-Box
‘CANNTG’ recognized by basic-helix–loop–helix (bHLH)
proteins (figure 3a,b). It is possible that other bHLH TFs,
such asHANDproteins, bind to the detectedmotif and interact
with NKX2-5 through PPIs, as shown previously for HAND2
[56]. For confirmed novel PPIs, we also tested their paralogues,
which we hypothesized could share the same motif. PRRX1a
and PRRX1b, paralogues of PRRX2, as well as IKZF3 and
IKZF5, paralogues of IKZF1, were confirmed as NKX2-5 inter-
actors. However, we did not validate RXRg, a paralogue of
RXRa, suggesting that overall homology or the presence of
PPI domains within paralogues is not necessarily a predictor
of binding. This is consistent with previous findings that
NKX2-5 could interact with NF1-B1 and NF1-B3 but not para-
logous factors NF1-A or NF1-X [16]. The evolutionary
significance of these PPIs in the context of NKX2-5 cardiacdevelopmental biology and the conservation of their predicted
genomic sites of interaction would benefit from further study.
Of the novel NKX2-5 PPIs predicted and validated, the
homeodomain protein PRRX2 and retinoic acid receptor
RXRa are expressed in the heart and play a role in heart devel-
opment [42,57]. IKZF1 has not been associated with cardiac
development and is better known for its role in haematopoietic
differentiation, tumour suppression and chromatin regulation
[58–60]. However, in the developing embryo, heart and
haemoangiogenic progenitor territories have close physical
relationships and share network regulators, which can act sup-
portively as well as antagonistically to define territory
boundaries [61–65]. Thus, it is conceivable that NKX2-5 and
IKZF1 interact in the establishment and/or maintenance of
these lineages, although further work is required to examine
this. Both RXRa and IKAROS (LYF-1) are novel NKX2-5 PPIs
that contain zinc-finger domains. NKX2-5 has been demon-
strated to interact with other zinc-finger domain proteins,
such as GATA4 [34], ZAC1/PLAGL1 [66] and CAL/FBLIM1
[67]. However, as observed in our Y2H assays, zinc-finger pro-
teins ZBTB11/12 and KLF10 did not interact, so binding to
zinc-finger domain proteins is not a generic feature of NKX2-5.
Perturbation of vitamin A (retinol) levels has long been
known to affect mammalian embryo development, with the
heart being the most sensitive organ [68,69]. Retinoic acid
(RA), a derivative of vitamin A, is an essential signalling mol-
ecule that controls many aspects of embryo development by
binding to RA receptors (RAR) and Retinoid X receptors
(RXR). Changes in RA concentrations in retinal dehydrogenase
(Raldh2)-deficient embryos leads to severe cardiac abnormal-
ities [70], and removal of Nkx2-5 in Raldh22/2 mice rescues
some of these defects [71], suggesting genetic cross-talk
between the RA and NKX2-5 pathways. Mice lacking RXRa
in the germline or conditionally in epicardium [72] display a
spectrum of cardiac defects arising from lack of expansion of
the myocardial compact zone and dysregulated trabecular
morphogenesis [42]. Defects in mice lacking Rxra and Raldh2
overlap with those reported in Nkx2-5 heterozygous and
hypomorphic mice, raising the possibility that physical inter-
action between NKX2-5 and RXRa at early stages of heart
development could be important for orchestrating normal
morphogenesis. Disruption of RXRa was recently associated
with the cardiac malformation tetralogy of Fallot [73], pre-
viously associated with mutations in NKX2-5 [46,74]. We
tested interactions between RXRa and five disease-causing
NKX2-5 homeodomain mutants [46–48], observing a weaker
interaction between RXRa and three of these (Q187H, R189G
and R190H; figure 5). This work shows that NKX2-5 homeo-
domain mutations causative for CHD may critically intersect
with RXRa pathways governing heart morphogenesis. Future
studies assessing the role of these novel NKX2-5 protein
interactions during normal development, evolution and in
the context of disease models will further allude to their
functional significance.4. Conclusion
Using a knowledge-based machine-learning approach, we
identified and validated a number of novel NKX2-5 protein
interactors, RXRa, PRRX2 and IKZF1/LYF-1, and their para-
logues PRRX1a, PRRX1b (two isoforms of PRRX1), and
IKZF3 and IKZF5. Furthermore, we have established a
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defects seen in patients carrying heterozygous NKX2-5 home-
odomain mutations may in part be due to disrupted PPIs
between NKX2-5 and RXRa. As far as we are aware, this is
the first study to systematically validate predicted PPIs of
TFs from DNA sequence alone.
Our study brings to light some key considerations. Com-
paring replicated experiments using a model-based approach
supported our previous findings of conserved gene ontologies
and indicated that motif grammar of NKX2-5 binding was
conserved in repeated experiments. Thus, variation of binding
sites identified between repeated experiments is not simply
noise. In the light of NKX2-5 being a highly studied and criti-
cal TF for heart development, we identified and validated
novel NKX2-5 PPIs from genome-wide DNA-binding data,
demonstrating the utility of machine-learning approaches for
systematic detection of TF binding partners. We propose that
these interactions represent but a small proportion of the com-
plex NKX2-5 PPI landscape that is difficult to probe using
traditional methods. Identifying novel TF-TF PPIs has the
potential to shed light on the complex gene regulatory pro-
cesses underlying normal development and, as we observed
for RXRa, provide new insights into disease processes.5. Material and methods
Bioinformatics analyses were performed in R v. 3.1.2 (www.
r-project.org) [75] using Bioconductor [76] packages unless
stated otherwise.
5.1. Datasets
BED files corresponding to the mm9 coordinates of N-terminal
NKX2-5 DamID peaks were downloaded from NCBI GEO
Accession, GSE44902 [16]. We name repeated experiments,
NKX2-51 [GSE44902, GSM1093634] and NKX2-52 [GSE44902,
GSM1328466]. A random dataset was generated of the same
set size and length distribution as NKX2-5 peaks using the per-
mutation strategy implemented in bedtools [77] and sampling
constrained to promoter regions represented on the micro-
array. Data were randomly partitioned for each NKX2-5 and
random dataset into 75% for training and 25% for testing.
5.2. Motif detection and counting for generating
feature matrices
DREME [23] was used for de novo motif discovery using
only training sets. All motifs discovered according to
default settings were reported. As DREME uses a one-way
Fisher’s exact test, we performed pairwise comparisons for
NKX2-51, NKX2-52 and random peaks.
For generating motif feature matrices, we first add the
PWMs of the de novo motifs discovered using DREME to a
motif (PWM) library derived from Transfac and Jaspar
public repositories, in addition to motifs from literature as
previously described [16]; n(motifs) ¼ 1132, bringing the
total number of motifs used for analysis to 1202. All motifs
are provided in electronic supplementary material, file S2.
CLOVER [27] was used to score PWM matches and each
peak normalized to motif per kilobase to account for differ-
ences in motif numbers and length. A motif instance was
recorded if it had at least the default minimum CLOVERscore of 6. Formatting of data into feature matrices for
input into R was performed using custom Perl scripts. Fea-
ture matrices, Mnp, used for classification were comprised
of npeaks by pmotifs/kb.
5.3. Machine-learning algorithms and performance
assessment
For generating lasso models, we used the ‘glmnet’ R library
(v. 1.9) [78]. The lasso selects features by shrinking less relevant
coefficients to zero through application of a l penalty (via L-1
regularization; the shrinkage parameter). Ten-fold cross-
validation was used to determine the value of l and unless
stated otherwise we used the l within 1 s.e. of the maximum
AUC. For SVM models, we used the ‘e1071’ R library (v. 1.6)
[79] and the linear kernel function. The penalization parameter,
C, was tuned using 10-fold cross-validation and a grid search
space of 1025 to 1 (identifying a C of 1024 for models with
and 1023 without de novo motifs). For random forests, we
used the ‘randomForest’ R library (v. 4.6) [80] with default par-
ameters. For generating receiver operator characteristic (ROC)
curves and calculating AUC, we used the ROCR package
(v. 1.0) [81]. Sensitivity and specificity analysis considered
the proportion of correctly classified true positive and true
negative peaks as per equations (5.1) and (5.2):
sensitivity ¼ true positive
true positiveþ false negative ð5:1Þ
specificity ¼ true negative
false positiveþ true negative ð5:2Þ
The positive predictive value (PPV) was calculated as
follows:
positive predictive value ¼ true positives
true positivesþ false positives
ð5:3Þ
The false discovery rate (FDR) of predictions was
calculated as follows:
false discovery rate ¼ false positivesP
predicted positives
ð5:4Þ
5.4. Yeast two-hybrid assay
Sequences coding for murine TFs MSX1, GMEB1, ZBTB11/12,
KLF10 and NFYC were amplified from HL-1 cell cDNA. CMV
AP-4 was a gift from Robert Tjian (Addgene plasmid # 12101)
[82]; pLuc-CDS was a gift from Kumiko UiTei (Addgene
plasmid # 42100) [83]; pBABE puro human RXRa was a gift
from Ronald Kahn (Addgene plasmid # 11441); PRRX2-pSG5
was a gift from Corey Largman (Addgene plasmid #21009)
[84]. A coding sequence was obtained from Origene for
IKZF1 (MR227509), IKZF3 (MR227380), PRRX1a (RC213276),
PRRX1b (RC210393) and RXRg (MR225349). The vectors
NpGBT9-AiolosF5-6 (M1-1 B9), NpGBT9-Eos-364-400 (M1-1
E9), pGBT9-Eos364-518 (M1-1 H6), pGBT9-Eos358-532 (M1-1
H8), NpGBT9-Pegasus (M1-1 I3), NpGBT9-Pegasus221-420
(M1-2 A1) and NpGBT9-PegasusF4-5 (M1-2 A2) were a gift
from Merlin Crossley [85].
All sequences were cloned into pGADT7 AD or pGBKT7
DBD expression vector backbones (Clontech), which were
modified to contain a Gateway cloning cassette (gift from
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were co-transformed into chemically competent S. cerevisiae
strain AH109 (Clontech). Double transformants were selected
for growth on ‘low stringency’ -Leu/-Trp selection plates,
before being selected for interaction on ‘high stringency’
-Ade/-His/-Leu/-Trp selection plates.
The monoclonal antibody 9E10 developed by Michael J.
Bishop was obtained from the Developmental Studies
Hybridoma Bank, created by theNICHDof theNIH andmain-
tained at the Department of Biology, University of Iowa, Iowa
City, IA 52242, USA.
5.5. Western blots
For protein extraction and western blotting, yeast colonies
selected on ‘low stringency’ (-Leu/-Trp) plates were
grown in 1.5 ml of liquid ‘low stringency’ medium at 308C
for 48 hours under agitation. Cultures were then transferred
directly to 10ml of fresh yeast extract protein peptone dex-
trose (YEPD) medium and further grown at 308C for 4–6
hours under agitation until the OD600 reached 0.4–1.0.
Protein extraction was then performed following the post-
alkaline extraction method [86]. In accordance with this
method, cultures were pelleted and resuspended in 100 ml
of distilled water per 2.5 OD600. Then, 100ml of 0.2M
NaOH was added per 2.5 OD600 and suspensions were
incubated at room temperature for 5 minutes. After
centrifugation, yeast cells were lysed in 50ml of SDS sample
buffer (0.06M Tris-HCl, pH 6.8; 5% glycerol; 2% SDS; 4%
b-mercaptoethanol; 0.0025% bromophenol blue) per 2.5
OD600 and boiled for 2 minutes. 20mL of lysed samples
were loaded on NuPage 10% bis-tris gels (Invitrogen).To detect GAL4-activation (AD)-HA fusion proteins, a
rabbit anti-HA antibody was obtained from Cell Signalling
(C29F4). To detect the GAL4-DNA-binding domain (DBD)-
c-Myc protein fusions, the monoclonal antibody 9E10 devel-
oped by Michael J. Bishop was obtained from the
Developmental Studies Hybridoma Bank, created by the
NICHD of the NIH and maintained at The University of
Iowa, Department of Biology, Iowa City, IA 52242. After
chemiluminescent detection, membranes were stained using
a Ponceau S solution to visualize the total protein levels in
each lane and control for equal loading. IMAGEJ (Rasband,
W.S., US National Institutes of Health, Bethesda, Maryland,
USA, http://imagej.nih.gov/ij, 1997–2016) was used to
quantify protein expression detected by western blotting.Data accessibility. Datasets are available at NCBI GEO: GSE44902
(GSM1093634) and GSE44902 (GSM1328466) and supporting data
have been uploaded as part of the electronic supplementary material.
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